Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of Denali Therapeutics Inc (NASDAQ: DNLI) closed at $12.55 in the last session, down -4.71% from day before closing price of $13.17. In other words, the price has decreased by -$4.71 from its previous closing price. On the day, 1.43 million shares were traded. DNLI stock price reached its highest trading level at $13.27 during the session, while it also had its lowest trading level at $12.37.
Ratios:
We take a closer look at DNLI’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 8.46 and its Current Ratio is at 8.46. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
On February 11, 2025, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $31.Deutsche Bank initiated its Buy rating on February 11, 2025, with a $31 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 06 ’25 when Ho Carole sold 12,255 shares for $20.22 per share. The transaction valued at 247,796 led to the insider holds 178,580 shares of the business.
Ho Carole sold 2,907 shares of DNLI for $60,495 on Jan 07 ’25. The Chief Medical Officer now owns 175,673 shares after completing the transaction at $20.81 per share. On Jan 06 ’25, another insider, Schuth Alexander O., who serves as the COFO and Secretary of the company, sold 12,255 shares for $20.22 each. As a result, the insider received 247,796 and left with 247,215 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DNLI now has a Market Capitalization of 1822448384 and an Enterprise Value of 1044444160.
Stock Price History:
The Beta on a monthly basis for DNLI is 1.51, which has changed by -0.24397588 over the last 52 weeks, in comparison to a change of 0.05279863 over the same period for the S&P500. Over the past 52 weeks, DNLI has reached a high of $33.33, while it has fallen to a 52-week low of $10.57. The 50-Day Moving Average of the stock is -23.45%, while the 200-Day Moving Average is calculated to be -44.53%.
Shares Statistics:
According to the various share statistics, DNLI traded on average about 1.27M shares per day over the past 3-months and 1701420 shares per day over the past 10 days. A total of 142.63M shares are outstanding, with a floating share count of 125.71M. Insiders hold about 13.43% of the company’s shares, while institutions hold 88.06% stake in the company. Shares short for DNLI as of 1743379200 were 11444098 with a Short Ratio of 9.00, compared to 1740700800 on 8893475. Therefore, it implies a Short% of Shares Outstanding of 11444098 and a Short% of Float of 9.21.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
